Frontiers | SARS-CoV-2 specific antibody trajectories in mothers and infants over two months following maternal infection

France Nouvelles Nouvelles

Frontiers | SARS-CoV-2 specific antibody trajectories in mothers and infants over two months following maternal infection
France Dernières Nouvelles,France Actualités
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

Infants less likely to contract COVID, develop severe symptoms than other household caregivers frontiersin

for a detailed description of assay validation and protocols). Sample seropositivity for anti-S RBD IgG and IgA was determined relative to negative controls , which were run in quadruplicate on all plates. Negative cutoff values for each plate were defined as the mean plus 3 standard deviations of the optical density for all four negative control wells.

IgG positive samples with sufficient remaining volume were tested again using a quantitative multiplex assay for measurement of IgG antibodies to both the SARS-CoV-2 S1 and S2 subunits . Lower and upper limits of detection for S1 and S2 assays were 97.5 – 75,000 U/mL. Cutoff values for the quantitative IgG assay were determined according to the kit protocol, and all sample results quantitatively assayed were positive after adjusting for the dilution factor.

Differences in maternal and infant antibody responses were further examined among the COVID+ group onlya series of Bayesian models. All models were run in R v. 4.1.1 using the ‘brms’ package to fit linear and generalized linear models with full Bayesian inference in Stan (

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

medical_xpress /  🏆 101. in UK

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Vimentin is an important co-receptor for SARS-CoV-2 infectionVimentin is an important co-receptor for SARS-CoV-2 infectionVimentin is an important co-receptor for SARS-CoV-2 infection Receptor SARSCoV2 Coronavirus Disease COVID ACE2 Vimentin iScience_CP IHU_Marseille univamu
Lire la suite »

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariantsBivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariantsResearchers at Emory University, Stanford University, and the National Institute of Allergy and Infectious Diseases evaluated whether bivalent coronavirus disease 2019 (COVID-19) boosters conferred protection against new Omicron subvariants.
Lire la suite »

Scientists identify a broadly neutralizing antibody against all dominant SARS-CoV-2 variantsScientists identify a broadly neutralizing antibody against all dominant SARS-CoV-2 variantsScientists identify a broadly neutralizing antibody against all dominant SARS-CoV-2 variants Antibody SARSCoV2 Coronavirus Disease COVID biorxivpreprint WeillCornell UWMadison scrippsresearch UChicago IcahnMountSinai seattlechildren
Lire la suite »

Scientists identify a cryptic SARS-CoV-2 lineage in wastewaterScientists identify a cryptic SARS-CoV-2 lineage in wastewaterIn a recent study posted to the medRxiv* preprint server, researchers in the United States investigated the source of an enigmatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC)-like spike (S) protein strain detected in wastewater but not in clinical samples.
Lire la suite »

SARS-CoV-2 infections may induce neuroinflammationSARS-CoV-2 infections may induce neuroinflammationSARS-CoV-2 infections may induce neuroinflammation ucdavis CellPressNews SARSCoV2 COVID19 Neuroinflammation Infection
Lire la suite »



Render Time: 2025-03-24 08:07:12